argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
13 jan 2026 - 07:00
Statutory name
argenx SE
Title
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
Related downloads
Date last update: 13 January 2026